Document is current
Any future updates will be listed below
-
Authors
Concha-Marambio, Luis http://orcid.org/0000-0002-9454-8389
Pritzkow, Sandra
Shahnawaz, Mohammad
Farris, Carly M.
Soto, Claudio http://orcid.org/0000-0002-3412-0524
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson’s Research
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS119689, NS119689)
- License Information
-
More Information
Article History
Received: 29 March 2022
Accepted: 10 October 2022
First Online: 18 January 2023
Competing interests
: L.C.-M. and C.M.F. are employees of Amprion Inc., a biotechnology company that focuses on the commercial use of SAAs (PMCA and RT-QuIC) for high-sensitivity detection of misfolded protein aggregates. C.S. is a Founder, Chief Scientific Officer and Member of the Board of Directors of Amprion Inc. The University of Texas Health Science Center at Houston has licensed patents and patent applications to Amprion. The other authors declare no competing interests.
